Liberty Wealth Management LLC Adaptive Biotechnologies Corp Transaction History

Liberty Wealth Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$25.17 - $36.85 $15,102 - $22,110	-600 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$32.22 - $44.59 $770,573 - $1.07 Million	-23,916 Reduced 97.55%	600 $25,000
Q2 2021 Aug 13, 2021	BUY	$32.22 - $44.59 $779,917 - $1.08 Million	24,206 Added 7808.39%	24,516 $600,000
Q1 2021 May 17, 2021	BUY	$37.26 - $67.74 $372 - $677	10 Added 3.33%	310 $18,000
Q4 2020 Feb 09, 2021	BUY	$45.01 - $65.47 $13,503 - $19,641	300 New	300 $16,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Liberty Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Liberty Wealth Management LLC with notifications on news.